Inventor · disambiguated record
Dirk Brehmer
Also filed as: BREHMER DIRK
12 granted patents·4 pending applications·17 citations·filing 2005–2023
85Inventor score
Top patents by PatentIndex Score
16 records- 0192US11702441B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 18, 2023·2 cites·2 claims
- 0292US11059850B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 13, 2021·8 cites·21 claims
- 0391US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0484US12145961B2Spirobicyclic analoguesJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Nov 19, 2024·0 cites·1 claims
- 0583US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 0677US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0777US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0874US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 0968US11999993B2Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jun 4, 2024·0 cites·8 claims
- 1068US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 1161US2023241087A1Methods Of Treating Cancer Using Prmt5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1260US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 1357US11279970B2Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 22, 2022·0 cites·8 claims
- 1450US11571437B2Methods of treating cancer using PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 7, 2023·0 cites·42 claims
- 1544US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
- 1636US2008187575A1Pyrimidine DerivativesKLEBL BERT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dirk Brehmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →